155 related articles for article (PubMed ID: 19702545)
1. Comparison of pharmacokinetics of cyclosporine A in cadaveric and living-related renal transplant recipients and in an experimental rat model of renal failure.
Sugioka N; Fujimoto K; Tanaka Y; Fukushima K; Ito Y; Kokuhu T; Okamoto M; Yoshimura N; Takada K
Drug Metab Lett; 2009 Aug; 3(3):152-61. PubMed ID: 19702545
[TBL] [Abstract][Full Text] [Related]
2. Effect of plasma uric acid on pharmacokinetics of cyclosporine A in living-related renal transplant recipients and pharmacokinetic study in rats with experimental hyperuricaemia.
Sugioka N; Takai M; Yoshida K; Yasuda K; Fukushima K; Kokuhu T; Okamoto M; Yoshimura N; Takada K
J Clin Pharm Ther; 2010 Jun; 35(3):323-32. PubMed ID: 20831533
[TBL] [Abstract][Full Text] [Related]
3. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
Canadian Neoral Renal Transplantation Study Group
Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].
Vavić N; Ignjatović L; Drasković B; Hrvacević R; Kovacević Z; Paunić Z
Vojnosanit Pregl; 2008 Feb; 65(2):119-27. PubMed ID: 18365668
[TBL] [Abstract][Full Text] [Related]
5. Long-term cyclosporin A pharmacokinetic profiles in pediatric renal transplant recipients.
Kelles A; Van Damme-Lombaerts R; Tjandra-Maga TB; Van Damme B
Transpl Int; 1996; 9(6):546-50. PubMed ID: 8914233
[TBL] [Abstract][Full Text] [Related]
6. C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.
Diciolla F; Scolletta S; Berti L; Maccherini M; Federici D; Bernazzali S; Lisi G; Chiavarelli M
Transplant Proc; 2005 Mar; 37(2):1355-9. PubMed ID: 15848719
[TBL] [Abstract][Full Text] [Related]
7. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
[TBL] [Abstract][Full Text] [Related]
8. CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics.
Song J; Kim MG; Choi B; Han NY; Yun HY; Yoon JH; Oh JM
Ann Pharmacother; 2012 Sep; 46(9):1141-51. PubMed ID: 22947591
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of cyclosporine A in Japanese renal transplant patients: comprehensive analysis in a single center.
Okada A; Ushigome H; Kanamori M; Morikochi A; Kasai H; Kosaka T; Kokuhu T; Nishimura A; Shibata N; Fukushima K; Yoshimura N; Sugioka N
Eur J Clin Pharmacol; 2017 Sep; 73(9):1111-1119. PubMed ID: 28620753
[TBL] [Abstract][Full Text] [Related]
10. Evidence of different pharmacokinetics including relationship among AUC, peak, and trough levels between cyclosporine and tacrolimus in renal transplant recipients using new pharmacokinetic parameter--why cyclosporine is monitored by C(2) level and tacrolimus by trough level--.
Takeuchi H; Matsuno N; Senuma K; Hirano T; Yokoyama T; Taira S; Kihara Y; Kuzuoka K; Konno O; Jojima Y; Mejit A; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Ashizawa T; Nagao T; Toraishi T; Okuyama K; Oka K; Unezaki S
Biol Pharm Bull; 2008 Jan; 31(1):90-4. PubMed ID: 18175948
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection.
Weber LT; Armstrong VW; Shipkova M; Feneberg R; Wiesel M; Mehls O; Zimmerhackl LB; Oellerich M; Tönshoff B;
Ther Drug Monit; 2004 Aug; 26(4):415-24. PubMed ID: 15257072
[TBL] [Abstract][Full Text] [Related]
12. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K
J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177
[TBL] [Abstract][Full Text] [Related]
13. Evolution of the therapeutic drug monitoring of cyclosporine.
Citterio F
Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
Zhang Y; Zhang XD; Wang Y
Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cyclosporine absorption profiles over a 12-month period in stable pediatric renal transplant recipients.
Wigger M; Drückler E; Muscheites J; Stolpe HJ; Kundt G; Wacke R
Transplant Proc; 2003 Jun; 35(4):1300-3. PubMed ID: 12826143
[TBL] [Abstract][Full Text] [Related]
16. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Neoral and Sandimmun cyclosporin A pharmacokinetic profiles in young renal transplant recipients.
Kabasakul SC; Clarke M; Kane H; Karsten J; Clark G
Pediatr Nephrol; 1997 Jun; 11(3):318-21. PubMed ID: 9203180
[TBL] [Abstract][Full Text] [Related]
18. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
[TBL] [Abstract][Full Text] [Related]
19. Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010.
Kokuhu T; Fukushima K; Ushigome H; Yoshimura N; Sugioka N
Int J Med Sci; 2013; 10(12):1665-73. PubMed ID: 24151438
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cyclosporine A after massive hepatectomy: a hint for small-for-size graft in living donor liver transplantation.
Shinohara H; Shimada M; Ogasawara T; Morine Y; Ikemoto T; Imura S; Fujii M
Dig Dis Sci; 2007 Oct; 52(10):2490-6. PubMed ID: 17431772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
